S. 1302In Committee
Increasing Transparency in Generic Drug Applications Act
Increase transparency in generic drug applications by requiring more public disclosure about the review process
Plain-English overview
What this bill does
Increase transparency in generic drug applications by requiring more public disclosure about the review process
Key points
- Require application review disclosure
Current status
Where it stands
Status
In Committee
Latest action
2025-04-03 — Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Related context
Topics and policy areas
undefinedHealth